Search Results - "Shaha, Suyog"

  • Showing 1 - 7 results of 7
Refine Results
  1. 1

    Strategies to improve the EPR effect: A mechanistic perspective and clinical translation by Ikeda-Imafuku, Mayumi, Wang, Lily Li-Wen, Rodrigues, Danika, Shaha, Suyog, Zhao, Zongmin, Mitragotri, Samir

    Published in Journal of controlled release (01-05-2022)
    “…Many efforts have been made to achieve targeted delivery of anticancer drugs to enhance their efficacy and to reduce their adverse effects. These efforts…”
    Get full text
    Journal Article
  2. 2

    Locoregional drug delivery for cancer therapy: Preclinical progress and clinical translation by Shaha, Suyog, Rodrigues, Danika, Mitragotri, Samir

    Published in Journal of controlled release (01-03-2024)
    “…Systemic drug delivery is the current clinically preferred route for cancer therapy. However, challenges associated with tumor localization and off-tumor toxic…”
    Get full text
    Journal Article
  3. 3

    Extracellular matrix degrading enzyme with stroma-targeting peptides enhance the penetration of liposomes into tumors by Ikeda-Imafuku, Mayumi, Gao, Yongsheng, Shaha, Suyog, Wang, Lily Li-Wen, Park, Kyung Soo, Nakajima, Mayuka, Adebowale, Omokolade, Mitragotri, Samir

    Published in Journal of controlled release (01-12-2022)
    “…Various anti-tumor nanomedicines have been developed based on the enhanced permeability and retention effect. However, the dense extracellular matrix (ECM) in…”
    Get full text
    Journal Article
  4. 4
  5. 5

    Immunotherapy against glioblastoma using backpack‐activated neutrophils by Fukuta, Tatsuya, Kumbhojkar, Ninad, Prakash, Supriya, Shaha, Suyog, Silva‐Candal, A. Da, Park, Kyung Soo, Mitragotri, Samir

    Published in Bioengineering & translational medicine (13-08-2024)
    “…Abstract Immune checkpoint inhibitors (ICIs) represent new therapeutic candidates against glioblastoma multiforme (GBM); however, their efficacy is clinically…”
    Get full text
    Journal Article
  6. 6

    A biomimetic chip to assess subcutaneous bioavailability of monoclonal antibodies in humans by Chandran Suja, Vineeth, Qi, Qin M, Halloran, Kevin, Zhang, Jifeng, Shaha, Suyog, Prakash, Supriya, Kumbhojkar, Ninad, Deslandes, Antoine, Huille, Sylvain, Gokarn, Yatin R, Mitragotri, Samir

    Published in PNAS nexus (01-10-2023)
    “…Abstract Subcutaneous (subQ) injection is a common route for delivering biotherapeutics, wherein pharmacokinetics is largely influenced by drug transport in a…”
    Get full text
    Journal Article
  7. 7